Cancer patients get continued access to lifesaving drug in new study
NCT ID NCT05629234
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers continued treatment with the cancer drug osimertinib to patients who have already benefited from it in a previous trial. The goal is to keep providing the drug while monitoring safety and side effects. About 37 adults with cancer who are still doing well on the drug will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100142, China
-
Research Site
Chongqing, 400042, China
-
Research Site
Yangzhou, 225001, China
-
Research Site
Zhengzhou, 450008, China
-
Research Site
Villejuif, 94805, France
-
Research Site
George Town, 10450, Malaysia
-
Research Site
Johor Bahru, 81100, Malaysia
-
Research Site
Kuantan, 25100, Malaysia
-
Research Site
Kuching, 93586, Malaysia
-
Research Site
Szczecin, 70-419, Poland
-
Research Site
Cheongju-si, 28644, South Korea
-
Research Site
Donggu, 44033, South Korea
-
Research Site
Goyang-si, 10408, South Korea
-
Research Site
Seongnam-si, 13620, South Korea
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Seoul, 06591, South Korea
-
Research Site
Seoul, 5505, South Korea
-
Research Site
Kaohsiung City, 83301, Taiwan
-
Research Site
Taichung, 40705, Taiwan
-
Research Site
Tainan, 704, Taiwan
-
Research Site
Tainan, 736, Taiwan
-
Research Site
Taipei, 112201, Taiwan
-
Research Site
Taoyuan, 333, Taiwan
-
Research Site
Nottingham, NG5 1PB, United Kingdom